drugset / Trial / NCT01689766
Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma
NaSingle-groupOpen-labelOther
Summary
Phase 2, multi-center, open-label, single-treatment group, baseline-controlled study to identify subjects with Folate Receptor-Positive Metastatic Renal Cell Carcinoma
Timeline
- Start
- 2003-11
- Primary completion
- 2007-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TECHNETIUM (99MTC) ETARFOLATIDE | Diagnostic / imaging agent | — | — |